Twenty five years since the first prospective study by Forman et al. (1991) on Helicobacter pylori and stomach cancer risk

Cancer Epidemiology

Volumn 41, Issue , 2016, Pages 159-164

  Sitas, Freddy ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Discovery; Epidemiology; Gastric cancer; Helicobacter pylori; Pathogenesis; Review; Stomach cancer

Indexed keywords

ANTIBIOTIC AGENT; HELICOBACTER PYLORI VACCINE; HISTAMINE H2 RECEPTOR AGONIST; PROTON PUMP INHIBITOR;

ANTIBIOTIC THERAPY; BACTERIAL LOAD; BACTERIUM DETECTION; CANCER RISK; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH CANCER; VACCINATION; COMPLICATION; DUODENUM ULCER; GASTRITIS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVALENCE; RISK; STOMACH NEOPLASMS;

DUODENAL ULCER; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; PREVALENCE; RISK; STOMACH NEOPLASMS;

EID: 84960812262     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2016.02.002     Document Type: Review

References (41)

1. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France : International Agency for Research on Cancer; 2013. Available from: (accessed on 30.11.15). http://globocan.iarc.fr.
2. Howson C.P., Hiyama T., Wynder E.L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 1986, 8:1-27. Review.
3. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988, 48(July (13)):3554-3560. Review.
4. Al-Dabbagh S., Forman D., Bryson D., Stratton I., Doll R. Mortality of nitrate fertiliser workers. Br. J. Ind. Med. 1986, 43:507-515.
5. Knight T.M., Forman D. The availability of dietary nitrate for the endogenous nitrosation of l-proline. IARC Sci. Publ. 1987, 84:518-523.
6. Knight T.M., Forman D., Al-Dabbagh S.A., Doll R. Estimation of dietary intake of nitrate and nitrite in Great Britain. Food Chem. Toxicol. 1987, 25:277-285.
7. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 16(June (1)):1311-1315.
8. Marshall B.J., Armstrong J.A., McGechie D.B., Glancy R.J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med. J. Aust. 1985, 142:436-439.
9. Atrophic Sipponen P. Gastritis as a premalignant condition. Ann. Med. 1989, 21:287-290.
10. Sitas F., Smallwood R., Jewell D., Millard P.R., Newell D.G., Meuwissen S.G., Moses S., Zwiers A., Forman D. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol. Biomarkers Prev. 1993, 2:119-123.
11. Newell D.G., Johnston B.J., Ali M.H., Reed P.I. An enzyme-linked immunosorbent assay for the serodiagnosis of Campylobacter pylori-associated gastritis. Scand. J. Gastroenterol. Suppl. 1988, 142:53-57.
12. Wald N., Idle M., Boreham J., Bailey A. Low serum vitamin A and subsequent risk of cancer: preliminary results of a prospective study. Lancet 1980, ii:813-815.
13. The Caerphilly and Speedwell Collaborative Group Caerphilly and Speedwell collaborative heart disease studies. J. Epidemiol. Community Health 1984, 38:259-262.
14. Forman D., Newell D.G., Fullerton F., Yarnell J.W., Stacey A.R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991, 302(June):1302-1305.
15. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., Sibley R.K. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991, 325:1127-1131.
16. Nomura A., Stemmermann G.N., Chyou P.H., Kato I., Perez-Perez G.I., Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991, 325:1132-1136.
17. Parsonnet J., Vandersteen D., Goates J., Sibley R.K., Pritikin J., Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J. Natl. Cancer Inst. 1991, 83:640-643. Erratum in: J. Natl. Cancer Inst. (1991) 83:881.
18. Jaskiewicz K., Louwrens H.D., Woodroof C.W., van Wyk M.J., Price S.K. The association of Campylobacter pylori with mucosal pathological changes in a population at risk for gastric cancer. S. Afr. Med J. 1989, 75:417-419.
19. Steininger H., Schneider U., Bartz K., Simmler B. [Campylobacter pylori and gastritis-the density of colonization and degree of inflammation: a semiquantitative and morphometric study]. Leber Magen Darm 1989, 19:70-78. [Article in German].
20. Feng Y.Y., Wang Y. Campylobacter pylori in patients with gastritis, peptic ulcer, and carcinoma of the stomach in Lanzhou, China. Lancet 1988, 1:1055.
21. Helicobacter and Cancer Collaborative Group Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001, 49:347-353. Review.
22. Wotherspoon A.C., Ortiz-Hidalgo C., Falzon M.R., Isaacson P.G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991, 338:1175-1176.
23. Harris A.W., Misiewicz J.J. Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet 1994, 343:1503.
24. Marshall B.J., Langton S.R. Urea hydrolysis in patients with Campylobacter pylori infection. Lancet 1986, 1:965-966.
25. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni J.F., Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402. Erratum in: Nature 412 (2001) 99.
26. IARC Working Group IARC Monographs on the evaluation of carcinogenic risks to humans. Biological Agents 2009, Vol. 100B. IARC, Lyon.
27. Plummer M., Franceschi S., Vignat J., Forman D., de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int. J. Cancer 2015, 136(January (2)):487-490. Epub 2014 Jun 11. 10.1002/ijc.28999.
28. Malfertheiner P., Megraud F., O'Morain C.A., Atherton J., Axon A.T., Bazzoli F., Gensini G.F., Gisbert J.P., Graham D.Y., Rokkas T., El-Omar E.M., Kuipers E.J., European Helicobacter Study Group Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012, 61:646-664. 10.1136/gutjnl-2012-302084.
29. Bashinskaya B., Nahed B.V., Redjal N., Kahle K.T., Walcott B.P. Trends in peptic ulcer disease and the identification of Helicobacter pylori as a causative organism: population-based estimates from the US Nationwide Inpatient Sample. J. Glob. Infect. Dis. 2011, 3:366-370. 10.4103/0974-777X.91061.
30. Eslick G.D. Pregnant women and the Helicobacter pylori generation effect. Helicobacter 2003, 8:643.
31. Ford A.C., Forman D., Hunt R.H., Yuan Y., Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 2014, 348(May):g3174. 10.1136/bmj.g3174.Review.
32. Figueiredo C., Machado J.C., Pharoah P., Seruca R., Sousa S., Carvalho R., Capelinha A.F., Quint W., Caldas C., van Doorn L.J., Carneiro F., Sobrinho-Simões M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 2002, 94:1680-1687.
33. McFarlane G., Forman D., Sitas F., Lachlan G. A minimum estimate for the incidence of gastric cancer in Eastern Kenya. Br. J. Cancer 2001, 85:1322-1325.
34. Kayamba V., Asombang A.W., Mudenda V., Lisulo M.M., Sinkala E., Mwanamakondo S., Mweemba I., Kelly P. Gastric adenocarcinoma in Zambia: a case-control study of HIV, lifestyle risk factors, and biomarkers of pathogenesis. S. Afr. Med. J. 2013, 103:255-259. 10.7196/samj.6159.
35. Newton R., Ziegler J.L., Casabonne D., Carpenter L., Gold B.D., Owens M., Beral V., Mbidde E., Parkin D.M., Wabinga H., Mbulaiteye S., Jaffe H., Uganda Kaposi's Sarcoma Study Group Helicobacter pylori and cancer among adults in Uganda. Infect. Agent Cancer 2006, 1(November):5.
36. Misra V., Pandey R., Misra S.P., Dwivedi M. Helicobacter pylori and gastric cancer: Indian enigma. World J. Gastroenterol. 2014, 20(February (6)):1503-1509. 10.3748/wjg.v20.i6.1503.Review.
37. Webb P.M., Yu M.C., Forman D., Henderson B.E., Newell D.G., Yuan J.M., Gao Y.T., Ross R.K. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int. J. Cancer 1996, 67:603-607.
38. Mitchell H.M., Ally R., Wadee A., Wiseman M., Segal I. Major differences in the IgG subclass response to Helicobacter pylori in the first and third worlds. Scand. J. Gastroenterol. 2002, 37:517-522.
39. Yamaoka Y., Kato M., Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern. Med. 2008, 47. 1077-83. Epub 2008 Jun 16. Review.
40. Zeng M., Mao X.H., Li J.X., Tong W.D., Wang B., Zhang Y.J., Guo G., Zhao Z.J., Li L., Wu D.L., Lu D.S., Tan Z.M., Liang H.Y., Wu C., Li D.H., Luo P., Zeng H., Zhang W.J., Zhang J.Y., Guo B.T., Zhu F.C., Zou Q.M. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2015, 386(10002):1457-1464. Epub 2015 Jun 30. 10.1016/S0140-6736(15)60310-5.
41. Sutton P. At last, vaccine-induced protection against Helicobacter pylori. Lancet 2015, 386(10002):1424-1425. Epub 2015 Jun 30. 10.1016/S0140-6736(15)60579-7.